Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm phase 2 study of intravenous difelikefalin in adolescents on hemodialysis with moderate-to-severe pruritus
CTR20253158Phase 2Active
- Sponsor
- CSL Vifor
- Start
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of difelikefalin in chronic kidney disease (CKD), sponsored by CSL Vifor. Started Sep 2026; status: active.
02
Drugs
difelikefalin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20253158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253158.